MTCO2P29

Across TCGA pan-cancer cohorts, MTCO2P29 RNA is linked to patient survival in 16 of 34 cancer types, making it the most broadly survival-associated MTCO2P29 data layer.

The strongest signal is observed in thyroid carcinoma (THCA), where higher MTCO2P29 RNA is associated with worse overall survival. In most high-consensus cancer types, elevated MTCO2P29 expression acts as an unfavorable survival marker, although some lineages such as KIRC and PRAD show a favorable association.

THCA, DLBC, and ACC are the cancer types where MTCO2P29 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
THCA	OS	Tertile	II,III,IV	0.523	0.892	<.001	156	view →
DLBC	DFS	Tertile	II,III,IV	0.065	0.829	<.001	54	view →
ACC	OS	Tertile	All	0.319	0.643	.016	36	view →
PAAD	OS	Tertile	All	0.229	0.544	.018	24	view →
KIRC	DFS	Tertile	IV	0.892	0.471	.006	20	view →
BLCA	OS	Tertile	IV	0.082	0.575	.002	18	view →
READ	DFS	Tertile	IV	0.141	0.671	<.001	18	view →
SKCM	OS	Tertile	All	0.202	0.781	<.001	18	view →
UCEC	OS	Tertile	All	0.883	0.930	.022	18	view →
PRAD	DFS	Tertile	All	1.000	0.926	.015	18	view →
LAML	DFS	Quartile	All	0.736	0.505	.012	16	view →
GBM	OS	Tertile	All	0.172	0.414	.040	9	view →

Pink = unfavorable, green = favorable. Showing the 12 strongest of 16 lineages.

MTCO2P29–THCA (OS)

Open the THCA breakdown →